Table of Content

1 Radiopharmaceuticals in Nuclear Medicine Market Overview
1.1 Radiopharmaceuticals in Nuclear Medicine Product Scope
1.2 Radiopharmaceuticals in Nuclear Medicine Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016 & 2021 & 2027)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Radiopharmaceuticals in Nuclear Medicine Segment by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Radiopharmaceuticals in Nuclear Medicine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Radiopharmaceuticals in Nuclear Medicine Price Trends (2016-2027)

2 Radiopharmaceuticals in Nuclear Medicine Estimates and Forecasts by Region
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2016-2021)
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2016-2021)
2.3 Global Radiopharmaceuticals in Nuclear Medicine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.2 Europe Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.3 China Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.4 Japan Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)
2.4.6 India Radiopharmaceuticals in Nuclear Medicine Estimates and Projections (2016-2027)

3 Global Radiopharmaceuticals in Nuclear Medicine Competition Landscape by Players
3.1 Global Top Radiopharmaceuticals in Nuclear Medicine Players by Sales (2016-2021)
3.2 Global Top Radiopharmaceuticals in Nuclear Medicine Players by Revenue (2016-2021)
3.3 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2020)
3.4 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Company (2016-2021)
3.5 Manufacturers Radiopharmaceuticals in Nuclear Medicine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type
4.1 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Review by Type (2016-2021)
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2016-2021)
4.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2016-2021)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2022-2027)
4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Type (2022-2027)
4.2.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2022-2027)

5 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application
5.1 Global Radiopharmaceuticals in Nuclear Medicine Historic Market Review by Application (2016-2021)
5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2016-2021)
5.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2016-2021)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2022-2027)
5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Application (2022-2027)
5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2022-2027)

6 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
6.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Company
6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
6.2 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
6.2.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
6.2.2 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
6.3 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
6.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2016-2021)
6.3.2 North America Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2022-2027)

7 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
7.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Company
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
7.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
7.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
7.3.1 Europe 154 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 154 Sales Breakdown by Application (2022-2027)

8 China Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
8.1 China Radiopharmaceuticals in Nuclear Medicine Sales by Company
8.1.1 China Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
8.1.2 China Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
8.2 China Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
8.2.1 China Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
8.2.2 China Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
8.3 China Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
8.3.1 China 173 Sales Breakdown by Application (2016-2021)
8.3.2 China 173 Sales Breakdown by Application (2022-2027)

9 Japan Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
9.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales by Company
9.1.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
9.1.2 Japan Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
9.2 Japan Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
9.2.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
9.3 Japan Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
10.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Company
10.1.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
10.1.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
10.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
10.2.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures
11.1 India Radiopharmaceuticals in Nuclear Medicine Sales by Company
11.1.1 India Radiopharmaceuticals in Nuclear Medicine Sales by Company (2016-2021)
11.1.2 India Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021)
11.2 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type
11.2.1 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2016-2021)
11.2.2 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Type (2022-2027)
11.3 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application
11.3.1 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2016-2021)
11.3.2 India Radiopharmaceuticals in Nuclear Medicine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medicine Business
12.1 Bracco Imaging S.P.A.
12.1.1 Bracco Imaging S.P.A. Corporation Information
12.1.2 Bracco Imaging S.P.A. Business Overview
12.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.1.5 Bracco Imaging S.P.A. Recent Development
12.2 Cambridge Isotope Laboratories, Inc.
12.2.1 Cambridge Isotope Laboratories, Inc. Corporation Information
12.2.2 Cambridge Isotope Laboratories, Inc. Business Overview
12.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.2.5 Cambridge Isotope Laboratories, Inc. Recent Development
12.3 Cardinal Health, Inc.
12.3.1 Cardinal Health, Inc. Corporation Information
12.3.2 Cardinal Health, Inc. Business Overview
12.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.3.5 Cardinal Health, Inc. Recent Development
12.4 Covidien, Plc
12.4.1 Covidien, Plc Corporation Information
12.4.2 Covidien, Plc Business Overview
12.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Products Offered
12.4.5 Covidien, Plc Recent Development
12.5 Eczacibasi-Monrol
12.5.1 Eczacibasi-Monrol Corporation Information
12.5.2 Eczacibasi-Monrol Business Overview
12.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Products Offered
12.5.5 Eczacibasi-Monrol Recent Development
12.6 Fujifilm Holdings Corporation
12.6.1 Fujifilm Holdings Corporation Corporation Information
12.6.2 Fujifilm Holdings Corporation Business Overview
12.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered
12.6.5 Fujifilm Holdings Corporation Recent Development
12.7 GE Healthcare (Subsidiary Of General Electric Company)
12.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
12.7.2 GE Healthcare (Subsidiary Of General Electric Company) Business Overview
12.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
12.8 IBA Group
12.8.1 IBA Group Corporation Information
12.8.2 IBA Group Business Overview
12.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Products Offered
12.8.5 IBA Group Recent Development
12.9 Isotec, Inc. (Sigma-Aldrich)
12.9.1 Isotec, Inc. (Sigma-Aldrich) Corporation Information
12.9.2 Isotec, Inc. (Sigma-Aldrich) Business Overview
12.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development
12.10 Lantheus Medical Imaging, Inc.
12.10.1 Lantheus Medical Imaging, Inc. Corporation Information
12.10.2 Lantheus Medical Imaging, Inc. Business Overview
12.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.10.5 Lantheus Medical Imaging, Inc. Recent Development
12.11 Nordion, Inc.
12.11.1 Nordion, Inc. Corporation Information
12.11.2 Nordion, Inc. Business Overview
12.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.11.5 Nordion, Inc. Recent Development
12.12 Ntp Radioisotopes (Pty), Ltd.
12.12.1 Ntp Radioisotopes (Pty), Ltd. Corporation Information
12.12.2 Ntp Radioisotopes (Pty), Ltd. Business Overview
12.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Development
12.13 Siemens Healthcare (Subsidiary Of Siemens AG)
12.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
12.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Business Overview
12.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
12.14 Taiyo Nippon Sanso Corporation
12.14.1 Taiyo Nippon Sanso Corporation Corporation Information
12.14.2 Taiyo Nippon Sanso Corporation Business Overview
12.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered
12.14.5 Taiyo Nippon Sanso Corporation Recent Development
12.15 Urenco Limited
12.15.1 Urenco Limited Corporation Information
12.15.2 Urenco Limited Business Overview
12.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Products Offered
12.15.5 Urenco Limited Recent Development
12.16 Rotem Industries, Ltd., Inc.
12.16.1 Rotem Industries, Ltd., Inc. Corporation Information
12.16.2 Rotem Industries, Ltd., Inc. Business Overview
12.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.16.5 Rotem Industries, Ltd., Inc. Recent Development
12.17 Australian Nuclear Association And Technology Organization (ANSTO)
12.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
12.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Business Overview
12.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
12.18 Board of Radiation And Isotope Technology (BRIT)
12.18.1 Board of Radiation And Isotope Technology (BRIT) Corporation Information
12.18.2 Board of Radiation And Isotope Technology (BRIT) Business Overview
12.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Development
12.19 Institute of Atomic Energy Polatom Radioisotope Centre
12.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
12.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Business Overview
12.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Products Offered
12.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
12.20 Institute of Isotopes Co., Ltd.
12.20.1 Institute of Isotopes Co., Ltd. Corporation Information
12.20.2 Institute of Isotopes Co., Ltd. Business Overview
12.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Products Offered
12.20.5 Institute of Isotopes Co., Ltd. Recent Development
12.21 Institute Of Radioelement (IRE)
12.21.1 Institute Of Radioelement (IRE) Corporation Information
12.21.2 Institute Of Radioelement (IRE) Business Overview
12.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Products Offered
12.21.5 Institute Of Radioelement (IRE) Recent Development

13 Radiopharmaceuticals in Nuclear Medicine Manufacturing Cost Analysis
13.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
13.4 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Radiopharmaceuticals in Nuclear Medicine Distributors List
14.3 Radiopharmaceuticals in Nuclear Medicine Customers

15 Market Dynamics
15.1 Radiopharmaceuticals in Nuclear Medicine Market Trends
15.2 Radiopharmaceuticals in Nuclear Medicine Drivers
15.3 Radiopharmaceuticals in Nuclear Medicine Market Challenges
15.4 Radiopharmaceuticals in Nuclear Medicine Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Radiopharmaceuticals in Nuclear Medicine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Radiopharmaceuticals in Nuclear Medicine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Region (2016-2021)
Table 5. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2016-2021)
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Region (2016-2021)
Table 8. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Company (2016-2021)
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Company (2016-2021)
Table 16. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2020)
Table 17. Global Radiopharmaceuticals in Nuclear Medicine Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Radiopharmaceuticals in Nuclear Medicine Manufacturing Sites and Area Served
Table 19. Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Type (2016-2021)
Table 22. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2016-2021)
Table 23. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Type (2016-2021)
Table 25. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2022-2027)
Table 26. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2022-2027)
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Type (2022-2027)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Application (2016-2021)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2016-2021)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Application (2016-2021)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Application (2022-2027)
Table 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2022-2027)
Table 35. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2022-2027)
Table 37. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Application (2022-2027)
Table 38. North America Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 39. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 40. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 42. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 43. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 44. North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 45. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 46. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 47. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 48. North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 49. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 50. Europe Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 51. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 52. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 54. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 55. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 56. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 57. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 58. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 59. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 60. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 61. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 62. China Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 63. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 64. China Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 66. China Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 67. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 68. China Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 69. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 70. China Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 71. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 72. China Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 73. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 74. Japan Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 75. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 76. Japan Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 78. Japan Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 79. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 80. Japan Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 81. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 82. Japan Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 83. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 84. Japan Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 85. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 98. India Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Company (2016-2021)
Table 99. India Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Company (2016-2021)
Table 100. India Radiopharmaceuticals in Nuclear Medicine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Company (2016-2021)
Table 102. India Radiopharmaceuticals in Nuclear Medicine Sales by Type (2016-2021) & (K MT)
Table 103. India Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2016-2021)
Table 104. India Radiopharmaceuticals in Nuclear Medicine Sales by Type (2022-2027) & (K MT)
Table 105. India Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2022-2027)
Table 106. India Radiopharmaceuticals in Nuclear Medicine Sales by Application (2016-2021) & (K MT)
Table 107. India Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2016-2021)
Table 108. India Radiopharmaceuticals in Nuclear Medicine Sales by Application (2022-2027) & (K MT)
Table 109. India Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2022-2027)
Table 110. Bracco Imaging S.P.A. Corporation Information
Table 111. Bracco Imaging S.P.A. Description and Business Overview
Table 112. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product
Table 114. Bracco Imaging S.P.A. Recent Development
Table 115. Cambridge Isotope Laboratories, Inc. Corporation Information
Table 116. Cambridge Isotope Laboratories, Inc. Description and Business Overview
Table 117. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 119. Cambridge Isotope Laboratories, Inc. Recent Development
Table 120. Cardinal Health, Inc. Corporation Information
Table 121. Cardinal Health, Inc. Description and Business Overview
Table 122. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 124. Cardinal Health, Inc. Recent Development
Table 125. Covidien, Plc Corporation Information
Table 126. Covidien, Plc Description and Business Overview
Table 127. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product
Table 129. Covidien, Plc Recent Development
Table 130. Eczacibasi-Monrol Corporation Information
Table 131. Eczacibasi-Monrol Description and Business Overview
Table 132. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product
Table 134. Eczacibasi-Monrol Recent Development
Table 135. Fujifilm Holdings Corporation Corporation Information
Table 136. Fujifilm Holdings Corporation Description and Business Overview
Table 137. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product
Table 139. Fujifilm Holdings Corporation Recent Development
Table 140. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 141. GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
Table 142. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product
Table 144. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 145. IBA Group Corporation Information
Table 146. IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. IBA Group Description and Business Overview
Table 148. IBA Group Radiopharmaceuticals in Nuclear Medicine Product
Table 149. IBA Group Recent Development
Table 150. Isotec, Inc. (Sigma-Aldrich) Corporation Information
Table 151. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Isotec, Inc. (Sigma-Aldrich) Description and Business Overview
Table 153. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product
Table 154. Isotec, Inc. (Sigma-Aldrich) Recent Development
Table 155. Lantheus Medical Imaging, Inc. Corporation Information
Table 156. Lantheus Medical Imaging, Inc. Description and Business Overview
Table 157. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 159. Lantheus Medical Imaging, Inc. Recent Development
Table 160. Nordion, Inc. Corporation Information
Table 161. Nordion, Inc. Description and Business Overview
Table 162. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 164. Nordion, Inc. Recent Development
Table 165. Ntp Radioisotopes (Pty), Ltd. Corporation Information
Table 166. Ntp Radioisotopes (Pty), Ltd. Description and Business Overview
Table 167. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product
Table 169. Ntp Radioisotopes (Pty), Ltd. Recent Development
Table 170. Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
Table 171. Siemens Healthcare (Subsidiary Of Siemens AG) Description and Business Overview
Table 172. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product
Table 174. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Development
Table 175. Taiyo Nippon Sanso Corporation Corporation Information
Table 176. Taiyo Nippon Sanso Corporation Description and Business Overview
Table 177. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product
Table 179. Taiyo Nippon Sanso Corporation Recent Development
Table 180. Urenco Limited Corporation Information
Table 181. Urenco Limited Description and Business Overview
Table 182. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product
Table 184. Urenco Limited Recent Development
Table 185. Rotem Industries, Ltd., Inc. Corporation Information
Table 186. Rotem Industries, Ltd., Inc. Description and Business Overview
Table 187. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 189. Rotem Industries, Ltd., Inc. Recent Development
Table 190. Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
Table 191. Australian Nuclear Association And Technology Organization (ANSTO) Description and Business Overview
Table 192. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product
Table 194. Australian Nuclear Association And Technology Organization (ANSTO) Recent Development
Table 195. Board of Radiation And Isotope Technology (BRIT) Corporation Information
Table 196. Board of Radiation And Isotope Technology (BRIT) Description and Business Overview
Table 197. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 198. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product
Table 199. Board of Radiation And Isotope Technology (BRIT) Recent Development
Table 200. Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
Table 201. Institute of Atomic Energy Polatom Radioisotope Centre Description and Business Overview
Table 202. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 203. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product
Table 204. Institute of Atomic Energy Polatom Radioisotope Centre Recent Development
Table 205. Institute of Isotopes Co., Ltd. Corporation Information
Table 206. Institute of Isotopes Co., Ltd. Description and Business Overview
Table 207. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 208. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product
Table 209. Institute of Isotopes Co., Ltd. Recent Development
Table 210. Institute Of Radioelement (IRE) Corporation Information
Table 211. Institute Of Radioelement (IRE) Description and Business Overview
Table 212. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 213. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product
Table 214. Institute Of Radioelement (IRE) Recent Development
Table 215. Production Base and Market Concentration Rate of Raw Material
Table 216. Key Suppliers of Raw Materials
Table 217. Radiopharmaceuticals in Nuclear Medicine Distributors List
Table 218. Radiopharmaceuticals in Nuclear Medicine Customers List
Table 219. Radiopharmaceuticals in Nuclear Medicine Market Trends
Table 220. Radiopharmaceuticals in Nuclear Medicine Market Drivers
Table 221. Radiopharmaceuticals in Nuclear Medicine Market Challenges
Table 222. Radiopharmaceuticals in Nuclear Medicine Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medicine Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2021 & 2027
Figure 3. Diagnostic Radiopharmaceuticals Product Picture
Figure 4. Therapy Radiopharmaceuticals Product Picture
Figure 5. Enriched Stable Isotopes Product Picture
Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2021 & 2027
Figure 7. Diagnostic Application Examples
Figure 8. Therapeutic Application Examples
Figure 9. Research Examples
Figure 10. Pharmaceutical Examples
Figure 11. Other Examples
Figure 12. Global Radiopharmaceuticals in Nuclear Medicine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) Growth Rate (2016-2027)
Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Radiopharmaceuticals in Nuclear Medicine Sales (K MT) Growth Rate (2016-2027)
Figure 20. Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Radiopharmaceuticals in Nuclear Medicine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Radiopharmaceuticals in Nuclear Medicine Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Radiopharmaceuticals in Nuclear Medicine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Radiopharmaceuticals in Nuclear Medicine Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Radiopharmaceuticals in Nuclear Medicine Players Market Share by Revenue in Radiopharmaceuticals in Nuclear Medicine: 2016 & 2020
Figure 31. Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2016-2021)
Figure 33. Global Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2016-2021)
Figure 35. Global Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2020
Figure 37. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2020
Figure 38. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2020
Figure 39. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2020
Figure 40. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2020
Figure 41. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2020
Figure 42. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2020
Figure 43. Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2020
Figure 44. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2020
Figure 45. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2020
Figure 46. India Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2020
Figure 47. India Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
Figure 50. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
Figure 51. Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed